LAURUSLABS — Laurus Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual income statement for Laurus Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	—	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	22,919	28,317	48,135	49,356	60,406
Cost of Revenue
Gross Profit	10,563	12,509	24,584	24,828	28,757
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	21,001	24,488	34,632	37,610	47,469
Operating Profit	1,918	3,829	13,504	11,746	12,936
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,198	2,936	13,011	10,839	11,089
Provision for Income Taxes
Net Income After Taxes	938	2,553	9,838	8,324	7,966
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	938	2,553	9,836	8,275	7,901
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	938	2,553	9,836	8,275	7,901
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.76	4.8	18.3	15.4	14.6
Dividends per Share